641 filings
S-1
TCON
TRACON Pharmaceuticals Inc
IPO registration
12 Apr 24
4:52pm
8-K
TCON
TRACON Pharmaceuticals Inc
12 Apr 24
Results of Operations and Financial Condition
4:43pm
424B5
TCON
TRACON Pharmaceuticals Inc
12 Apr 24
Prospectus supplement for primary offering
4:36pm
8-K
TCON
TRACON Pharmaceuticals Inc
10 Apr 24
Other Events
8:05am
8-K
TCON
TRACON Pharmaceuticals Inc
8 Apr 24
TRACON Pharmaceuticals Announces Reverse Stock Split
9:15am
SC 13G/A
6xbcu
5 Apr 24
Tracon Pharmaceuticals / Ikarian Capital ownership change
4:10pm
8-K
i6w9 ina0
3 Apr 24
ENVASARC Trial is Fully Enrolled and Final Data are Expected in Third Quarter 2024
8:05am
SC 13G/A
go47a1nw7al69g96pahy
19 Mar 24
Tracon Pharmaceuticals / aaronson wayne ownership change
11:20am
4
mzugkz
13 Mar 24
Tracon Pharmaceuticals / Scott B. Brown ownership change
5:59pm
4
7zvoo2js8un qdb
13 Mar 24
Tracon Pharmaceuticals / CHARLES THEUER ownership change
5:56pm
S-8
ly7gmqlmuqh
7 Mar 24
Registration of securities for employees
5:03pm
8-K
rtums5pwhkel 0qjpx
5 Mar 24
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
4:08pm
SC 13G/A
c14shrb3
14 Feb 24
Tracon Pharmaceuticals / Lincoln Park Capital Fund ownership change
4:31pm
SC 13D/A
6pyg78oo
9 Feb 24
Tracon Pharmaceuticals / Opaleye Management ownership change
4:05pm
8-K
xj92a36h85a
19 Dec 23
Other Events
5:00pm
8-K
9ukzop4a0cp u6bd5h7
8 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
w53dx i652t
20 Nov 23
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment
8:05am
4
ytfn5qfogvcsvge
14 Nov 23
Change in insider ownership
12:00am